Everett Collection / Shutterstock.com
With its roots stretching back to oil company Shell, Crystallics underpins pharmaceutical research and development by investigating the crystalline structures of drugs and potential drug compounds. LSIPR reports.
Crystallics is a company based in Amsterdam that evaluates drug ingredients for the pharmaceutical industry. It is one of a handful of companies globally that underpins pharmaceutical research and development by investigating the crystalline structures of drugs and potential drug compounds to find their optimum form. Such research can be crucial to effective patent protection when a drug comes to market.
Marcel Hoffmann, chief scientific officer at Crystallics, recommends that his firm gets involved in IP early in the research chain. Even if a pharma company has existing IP, it may not be well covered, he says.
For example, if a company already has its own prior art, it may leave gaps and make it more difficult to secure patent protection.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Crystallics; patents; pharmaceuticals
